Effects of Maternal Gut Microbiota-Targeted Therapy on the Programming of Nonalcoholic Fatty Liver Disease in Dams and Fetuses, Related to a Prenatal High-Fat Diet.

MLA

Yu, Hong-Ren, et al. “Effects of Maternal Gut Microbiota-Targeted Therapy on the Programming of Nonalcoholic Fatty Liver Disease in Dams and Fetuses, Related to a Prenatal High-Fat Diet.” Nutrients, vol. 14, no. 19, Sept. 2022. EBSCOhost, https://doi.org/10.3390/nu14194004.

APA

Yu, H.-R., Sheen, J.-M., Hou, C.-Y., Lin, I.-C., Huang, L.-T., Tain, Y.-L., Cheng, H.-H., Lai, Y.-J., Lin, Y.-J., Tiao, M.-M., & Tsai, C.-C. (2022). Effects of Maternal Gut Microbiota-Targeted Therapy on the Programming of Nonalcoholic Fatty Liver Disease in Dams and Fetuses, Related to a Prenatal High-Fat Diet. Nutrients, 14(19). https://doi.org/10.3390/nu14194004

Chicago

Yu, Hong-Ren, Jiunn-Ming Sheen, Chih-Yao Hou, I-Chun Lin, Li-Tung Huang, You-Lin Tain, Hsin-Hsin Cheng, et al. 2022. “Effects of Maternal Gut Microbiota-Targeted Therapy on the Programming of Nonalcoholic Fatty Liver Disease in Dams and Fetuses, Related to a Prenatal High-Fat Diet.” Nutrients 14 (19). doi:10.3390/nu14194004.